PITTSBURGH & CHICAGO--(BUSINESS WIRE)--This Thanksgiving, HEINZ, the global leader in condiments and market leader of US gravy,1 is turning its attention to the day after Thanksgiving with the debut of HEINZ Leftover Gravy. The first-ever squeezable bottle of HEINZ Homestyle Turkey Gravy transforms the Thanksgiving staple into a condiment perfectly poised for the ultimate leftover sandwich. Thanksgiving has evolved into more than just one meal — it's a multiday celebration. 94 percent of Americ.

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has expanded its Spectrum Therapeutics portfolio in Australia with the availability of new softgel capsules, further enhancing the Company's medical cannabis offerings in the region. The formats include Spectrum Yellow Cannabis Oil Softgels (CBD 20mg), Spectrum Red Cannabis.

More Than Half Plan to Expand Their Businesses, While Many Remain Worried About Inflation, Interest Rates, Supply Chains and Healthcare Costs CHARLOTTE, N.C. , Nov. 18, 2025 /PRNewswire/ -- Small and mid-sized business owners are cautiously optimistic about the coming year, with 74% expecting revenue increases and nearly 60% planning to expand their businesses, according to the 2025 Bank of America Business Owner Report, conducted in partnership with the Bank of America Institute.

NEW YORK--(BUSINESS WIRE)--Ziff Davis, Inc. (NASDAQ: ZD), today announced its participation in two investor conferences in December. Details of the conferences are as follows: UBS Global Technology and AI Conference Location: The Phoenician, Scottsdale, AZ Date and time: December 3, 2025, 7:35 am (MT) Webcast: https://cc.webcasts.com/ubsx001/120125a_js/?entity=77_84H38W5 Barclays Global Technology Conference Location: The Palace Hotel, San Francisco, CA Date and time: December 10, 2025 Webcast:.

NEW YORK--(BUSINESS WIRE)--Klarna, the global digital bank and flexible payments provider, announced today that investment funds managed by Elliott Investment Management, a U.S.-based investment firm, will purchase Klarna's U.S. Fair Financing loans, supporting the continued expansion of this product in the United States. The companies expect to facilitate a total of $6.5bn-worth of loans over the two-year term of the agreement. The agreement enables Klarna to sell part of its existing Fair Fin.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vyome Holdings Third Quarter 2025 Earnings Release.

SAN MATEO, Calif.--(BUSINESS WIRE)--Roblox Corporation (NYSE: RBLX), an immersive gaming and creation platform, today announced it is in the process of rolling out age-based chat, following its announcement in September. Roblox will be the first online gaming or communication platform to require age checks for communication, which the company hopes sets a new industry standard. Age-based chat is designed to limit conversations to users with similar ages, as appropriate. All users can now volunt.

EDAP to Present at Piper Sandler 37th Annual Healthcare Conference Company to Present and Host 1x1 Investor Meetings on Tuesday, December 2 nd , 2025 AUSTIN, Texas, November 18, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Chief Executive Officer Ryan Rhodes is scheduled to present and, together with Chief Financial Officer Ken Mobeck, will host 1x1 investor meetings at the upcoming Piper Sandler 37th Annual Healthcare Conference in New York City. Date: Tuesday, December 2nd Time: 10:30-10:55 am ET (fireside discussion) Format: Fireside discussion and 1x1 investor meetings …

EN 9120 aerospace certification elevates quality, traceability and compliance for distribution of commercial aircraft parts.

NEWARK, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2025 with the following results:

NASHVILLE, Tenn., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the acquisition of Melt Pharmaceuticals, Inc. (Melt), a clinical-stage pharmaceutical company pioneering non-opioid, non-IV therapies for sedation for medical procedures in the hospital, outpatient, and in-office settings. Melt's product candidates, MELT-210, MELT-300, and MELT-400, are based on the proprietary Zydis® ODT (oral dissolving tablet) drug delivery platform. The closing of the Melt acquisition marks a strategic expansion of Harrow's portfolio and reinforces its commitment to delivering innovative therapies that improve patient outcomes.

PHOENIX, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (“Mesa” or the “Company”) (Nasdaq: MESA) announced today that shareholders approved all proposals presented at the Company's special meeting of shareholders, including the proposal to adopt the agreement and plan of merger with Republic Airways Holdings Inc. (“Republic”)

PHILADELPHIA , Nov. 18, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Heidrick & Struggles International, Inc. (NASDAQ: HSII) (“Heidrick”) stockholders to determine whether the buyout price undervalues the company's shares.

PHILADELPHIA , Nov. 18, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating the recently announced proposed buyout of Electronic Arts Inc. (NASDAQ: EA) (“EA” or the "Company") shareholders to determine whether the buyout agreement is fair to the Company's investors.

TEL AVIV, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) -- REE Automotive Ltd. (Nasdaq: REE), an automotive technology company that develops software-defined vehicle (SDV) technology solutions, today announced a strategic collaboration with Mitsubishi Fuso Truck and Bus Corporation (Mitsubishi Fuso) through a memorandum of understanding (MoU)1 to collaborate and develop a software-defined vehicle (SDV) using REE's zonal SDV architecture and x-by-wire (XBW) technology. A one-year evaluation phase has commenced with the two companies working together to convert a Mitsubishi Fuso eCanter electric truck into an SDV, powered by REE's Zonal Architecture SDV technology. This collaboration permits Mitsubishi Fuso to assess the …

ANN ARBOR, Mich., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that HLS Therapeutics Inc. (TSX: HLS), the Company's partner in Canada for the development and commercialization of NILEMDO® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe), has received approval from Health Canada to market NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease. Commercial launch for NILEMDO is expected in Q2 2026.

Advancing U.S. Microelectronics Leadership Through Strategic Collaboration Advancing U.S. Microelectronics Leadership Through Strategic Collaboration

Vancouver, British Columbia--(Newsfile Corp. - November 18, 2025) - NexMetals Mining Corp. (TSXV: NEXM) (NASDAQ: NEXM) ("NEXM" or the "Company") announces that it has granted annual equity incentive awards to certain directors, officers, employees and consultants pursuant to the Company's Omnibus Equity Incentive Plan (the "Plan"). The Board of Directors has approved the grant of restricted share units ("RSUs") representing an aggregate of 332,512 common shares to certain officers, employees and consultants.

Strengthens Intellectual Property Portfolio and Provides Protection for Therapeutic Combination in Acclaim-3 Clinical Trial AUSTIN, Texas , Nov. 18, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX ), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the United States Patent and Trademark Office (USPTO) has granted Genprex a patent that covers the use of the Company's lead drug candidate, Reqorsa® Gene Therapy, in combination with PD-L1 antibodies, such as Tecentriq®, through 2037. "We continue to build protection around our lead drug candidate, REQORSA, and this new …

Protiviti is honored by Microsoft for outstanding achievement and innovation MENLO PARK, Calif. , Nov. 18, 2025 /PRNewswire/ -- Global consulting firm Protiviti has been selected for the AI Business Solution's 2025-2026 Microsoft Inner Circle.